Interpace Biosciences (IDXG) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for November 12, 2024, will be held virtually to increase access and reduce costs.

• Only stockholders of record as of September 18, 2024, are entitled to vote.

• Proxy materials are provided electronically, with options for mail or email delivery upon request.

Voting matters and shareholder proposals

• Main proposal is the ratification of EisnerAmper, LLP as the independent registered public accounting firm for fiscal year ending December 31, 2024.

• Board recommends a vote FOR the ratification of EisnerAmper.

• No other specific shareholder proposals or director elections are scheduled; other business may be transacted as appropriate.

Board of directors and corporate governance

• Board consists of five members divided into three classes, with staggered three-year terms.

• Series B Preferred Stock holders have rights to designate directors based on their holdings.

• Board committees include Audit, Compensation, Nominating, and Regulatory Compliance, all comprised of independent directors except the Chairman.

• Corporate governance documents and code of conduct are available online.